Obesity Drugs: Market Dynamics and Growth Potential - Report
Download the free report
This FT Live report explores the surge in GLP-1 weight loss drugs and the market dynamics driving a potential $100bn sector. It examines competition, access challenges and the wider economic impact of obesity treatments.
Receive exclusive personalised training and events invitations, carefully-curated offers and promotions from Financial Times by Email.
If you choose not to tick this box, you'll be unsubscribed from our marketing communications and miss out on information about relevant events and services that may be of interest.
You will continue to receive service emails related to the event.
Receive exclusive personalised events invitations, carefully-curated offers and promotions from Financial Times by Phone.
<p style="text-align: center;"><span style="font-size: 20px;">Thank you for completing the form.</span></p> <p style="text-align: center;"><span style="font-size: 20px;"><a href="https://brxcdn.com/fts-app-storage/d6e5bd4c-9228-11eb-a414-9a67e462410e/media/original/bdeb0596-f5c0-11ee-bdb0-769fd93813a2"><strong>Click here to download the Industry report</strong></a>.<br /></span></p> <p style="text-align: center;"><span style="font-size: 20px;">If you have any questions about the event, please contact the team at </span><a href="mailto:ftlive@ft.com"><span style="font-size: 20px;">ftlive@ft.com</span></a>.</p>
THE EARLY BIRD
IN-PERSON PASS
Gain access to in-person sessions and networking drinks. Network and connect with your peers.
$2,329
Full price $2,849 from March 9th, 2026.
THE EARLY BIRD
DIGITAL PASS
Access to live talks, Q&A and video on demand. Join from the comfort of your home or office.
$359
Full price $459 from March 9th, 2026